Aug 6, 2026 05:14AM
May 5, 2026 03:40AM
Dec 10, 2025 06:00PM
Sep 16, 2025 03:35AM
Sep 5, 2025 04:46AM
Aug 7, 2025 02:35AM
Jun 25, 2025 07:00AM Senhwa Biosciences Highlights Breakthroughs in Dual First-in-Class Drug Programs at Annual Shareholders' Meeting Today
Oct 14, 2024 07:00AM
Sep 17, 2024 10:06PM
Sep 13, 2024 01:49AM
Sep 8, 2024 10:33PM
Aug 6, 2024 08:49PM
Jul 11, 2024 08:35PM
Apr 3, 2024 07:00AM AACR 2024 Annual Meeting-Visit Senhwa Biosciences Exhibit Booth
Mar 20, 2024 07:00AM
Dec 26, 2023 07:00AM
Nov 9, 2023 07:00AM
Oct 19, 2023 08:00AM
Oct 31, 2022 07:00AM
Jun 6, 2022 09:00AM
Mar 28, 2022 07:00AM At the 2022 AAD Annual Meeting, Senhwa Presents Positive Initial Data from Clinical Trial of Silmitasertib Used to Treat Patients with Advanced Basal Cell Carcinoma
Jan 25, 2022 07:00AM
Jan 20, 2022 07:00AM
Dec 17, 2021 07:00AM
Dec 16, 2021 07:00AM
Nov 15, 2021 07:00AM
Oct 20, 2021 08:52AM
Sep 27, 2021 07:20AM Senhwa Announces Acceptance of Early Positive COVID-19 Phase II Study Abstract for Presentation at the ISIRV-WHO Conference
Aug 31, 2021 07:00AM
Aug 18, 2021 10:57PM
Aug 16, 2021 03:29AM
Aug 13, 2021 10:48PM
Jun 23, 2021 07:00AM
Jan 21, 2021 11:00PM
Jan 15, 2021 09:00AM Senhwa Biosciences Presents Positive Cholangiocarcinoma Data
Dec 23, 2020 09:40PM
Dec 13, 2020 09:09PM
Dec 3, 2020 09:17AM
Nov 25, 2020 09:34PM
Nov 6, 2020 09:00AM
Nov 2, 2020 09:00AM
Sep 11, 2020 08:34PM Coronavirus Breakthrough: Senhwa Reports First eIND Silmitasertib Treated Severe COVID-19 Patient - Discharged Following Five Days of Treatment
Jul 7, 2020 09:00AM
Jul 1, 2020 09:00AM
Mar 31, 2020 07:00AM
Apr 17, 2019 07:00AM
Nov 1, 2018 01:30AM
Jun 12, 2018 09:00AM

329,074 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All